IFP Advisors’s Akari Therapeutics AKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68K Hold
181
– – ﹤0.01% 4302
2026
Q2
$1.85K Sell
181
-7,250
-98% -$62.5K ﹤0.01% 4266
2026
Q1
$1.81K Buy
+7,431
New +$69.5K ﹤0.01% 3997
2018
Q2
– Sell
-1
Closed -$4K – 3858
2018
Q1
$4K Hold
1
– – ﹤0.01% 3236
2017
Q4
$4K Buy
+1
New +$3.86K ﹤0.01% 3284

Other funds holding AKTX

IFP Advisors's AKTX Position: Q3 2026 in Review

IFP Advisors held its Akari Therapeutics (AKTX) position steady in Q3 2026 at 181 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4302.

IFP Advisors first reported a position in AKTX in Q4 2017 and has held it in 5 quarters since. The position peaked at $4K in Q1 2018. 13 funds tracked by Wall St. Rank hold AKTX as of Q3 2026.

  • IFP Advisors held 181 shares of Akari Therapeutics worth $1.68K as of Q3 2026.
  • IFP Advisors left its Akari Therapeutics share count unchanged in Q3 2026.
  • Akari Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4302 holding.
  • IFP Advisors first reported a position in Akari Therapeutics in Q4 2017 and has held it in 5 quarters since.
  • IFP Advisors's Akari Therapeutics position peaked at $4K in Q1 2018.
  • 13 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.